Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
Crown Bioscience a global contract research organization CRO and JSR Life Sciences company has announced that its collaborative work with HanX Biopharmaceutical Co. Ltd. HanX employing a unique and broad portfolio of preclinical modeling in support of HanXs successful FDA Investigational New Drug IND application has been published in Scientific Reports a journal within the Nature portfolio.
Source: businesswireindia.com